<DOC>
<DOCNO>EP-0643712</DOCNO> 
<TEXT>
<INVENTION-TITLE>
SPIRO-OXETANES, PROCESS FOR PREPARING THE SAME AND MEDICAMENTS
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D49310	A61P1700	A61K31335	A61P100	A61P1100	A61P2900	A61K31337	C07D49300	C07D30514	A61K3133	A61K31337	A61P1100	A61K31365	A61P2900	A61P1700	A61K31335	A61K3133	A61P100	C07D30500	A61K31365	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	A61P	A61K	A61P	A61P	A61P	A61K	C07D	C07D	A61K	A61K	A61P	A61K	A61P	A61P	A61K	A61K	A61P	C07D	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D493	A61P17	A61K31	A61P1	A61P11	A61P29	A61K31	C07D493	C07D305	A61K31	A61K31	A61P11	A61K31	A61P29	A61P17	A61K31	A61K31	A61P1	C07D305	A61K31	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Pharmaceutical agents containing a compound of 
formula I in addition to conventional carrier and 

auxiliary substances 

 
in which 


A and B
which are the same or different, each 
denote a phenyl residue which is 

substituted if desired, by halogen, 
hydroxy, C
1
-C
6
 alkyl or C
1
-C
6
 alkoxy or 
together denote the group -CH=CH-CO-CH=CH-, 
X
denotes oxygen and Y denotes a methylene group 
or 
X
denotes the group -CH
2
O- and Y is a valency 
bond and 
R
denotes a spiro-linked C
3
-C
6
 cycloalkane 
residue or a spiro-linked C
3
-C
6
 lactone 
residue, 
 
their enantiomers, diastereomers and racemates.  

 
Use of compounds of formula I as claimed in claim 1 
for the treatment of acute and chronic allergic, 

non-allergic and traumatic inflammatory diseases. 
Compounds of formula I 

 
in which 


A and B
which are the same or different, each 
denote a phenyl residue which is 

substituted if desired, by halogen, 
hydroxy, C
1
-C
6
 alkyl or C
1
-C
6
 alkoxy or 
together denote the group -CH=CH-CO-CH=CH-, 
X
denotes oxygen and Y denotes a methylene group 
or 
X
denotes the group -CH
2
O- and Y is a valency 
bond and 
R
denotes a spiro-linked C
3
-C
6
 cycloalkane 
residue or a spiro-linked C
5
 or C
6
 lactone 
residue, 
 
their enantiomers, diastereomers and racemates.  

 
Compounds of formula I 

 
in which 


A and B
which are the same or different, each 
denote a phenyl residue which is 

substituted if desired, by halogen, 
hydroxy, C
1
-C
6
 alkyl or C
1
-C
6
 alkoxy, 
x
denotes oxygen and Y denotes a methylene group 

or 
x
denotes the group -CH
2
O- and Y is a valency 
bond and 
R
denotes a spiro-linked C
3
 or C
4
 lactone 
residue, 
 
their enantiomers, diastereomers and racemates. 
5-dioxadispiro[3.1.5.1]-dodeca-7,10-dien-2,9-dione. 
Process for the production of compounds of 
formula I as claimed in one of the claims 3 to 5,
  
 

wherein either 

a) a compound of the general formula II 

 
in which A and B have the above-mentioned 

meaning
 
is reacted in a well-known manner with a 

compound of the general formula III 

H
2
C=速
 
in which 速 

has the meaning stated above or 
b) a compound of the general formula IV 

 
in which A and B have the meaning stated above
 
is reacted in a well-known manner with a 

compound of the general formula V 

O=速
  
 

in which 速 
has the meaning stated above,
 
the reaction mixture obtained is processed, the 

compounds of formula I are isolated and 
subsequently if desired the compounds I obtained 

are resolved into their enantiomers or 
diastereomers. 
</CLAIMS>
</TEXT>
</DOC>
